.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Citi
Dow
Fish and Richardson
McKinsey
UBS
Moodys
Teva
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

Citalopram hydrobromide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for citalopram hydrobromide and what is the scope of citalopram hydrobromide patent protection?

Citalopram hydrobromide
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Forest Labs, Apotex Inc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Silarx, West-ward Pharms Int, Biovail Labs Intl, Actavis Elizabeth, Amneal Pharms Ny, Aurobindo, Cipla Ltd, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, G And W Labs Inc, Glenmark Generics, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Pliva, Roxane, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, Teva Pharms, Torpharm, Torrent Pharms, and Watson Labs, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-six drug master file entries for citalopram hydrobromide. Sixty-nine suppliers are listed for this compound.

Pharmacology for citalopram hydrobromide

Medical Subject Heading (MeSH) Categories for citalopram hydrobromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Biovail Labs IntlCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET, ORALLY DISINTEGRATING;ORAL021763-003Dec 20, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TorpharmCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL077046-002Nov 24, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TorpharmCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL077046-003Nov 24, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
RoxaneCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL077041-003Nov 23, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL077033-001Oct 28, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL077033-002Oct 28, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Torrent PharmsCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL078216-001Mar 27, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Epic PharmaCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL077045-001Apr 29, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL077032-001Nov 12, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanCITALOPRAM HYDROBROMIDEcitalopram hydrobromideTABLET;ORAL077042-001Nov 5, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Covington
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Medtronic
Moodys
Federal Trade Commission
McKinsey
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot